Basic Information
Basic information for LINC01010-213-12aa
Peptide Name LINC01010-213-12aa
Genome Position chr6:134502798-134502833[+]
Species Human
Peptide Sequence MSGDFLEAGAHK
Peptide Length 12
Unique No (LINC01010-201-12aa-2,LINC01010-202-12aa,LINC01010-203-12aa,LINC01010-204-12aa,LINC01010-205-12aa,LINC01010-206-12aa,LINC01010-207-12aa,LINC01010-208-12aa,LINC01010-209-12aa,LINC01010-210-12aa,LINC01010-211-12aa,LINC01010-212-12aa,LINC01010-214-12aa,LINC01010-215-12aa,LINC01010-216-12aa)
Grand Average of Hydropathicity -0.3
Relative Molecular Mass 1460.56
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000236700;LINC01010
Transcript ID/Name ENST00000666623;LINC01010-213
Transcript Length 1825
Coding Ability 0.4537
DNA Sequence Corresponding to Peptide ATGTCTGGAGACTTCTTGGAAGCTGGAGCACACAAA
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :